Aurinia Pharmaceuticals (AUPH) Operating Margin (2019 - 2026)

Aurinia Pharmaceuticals' Operating Margin history runs 8 years deep, the most recent figure standing at 53.31% for Q1 2026.

• Quarterly Operating Margin rose 1833.0% year-over-year to 53.31% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 41.73% (up 2944.0% YoY) and the FY2025 annual result came in at 37.06%, up 3906.0% from the prior year.
• Operating Margin was 53.31% for Q1 2026 at Aurinia Pharmaceuticals, up from 43.1% in the prior quarter.
• Across five years, Operating Margin topped out at 53.31% in Q1 2026 and bottomed at 175.18% in Q1 2022.
• A 5-year average of 26.66% and a median of 17.03% in 2022 frame the typical range for Operating Margin.
• Annual changes were most pronounced in 2022 — Operating Margin soared 535469 bps — and 2023, when it slumped 1280 bps.
• Aurinia Pharmaceuticals' Operating Margin stood at 98.82% in 2022, then jumped by 33 bps to 65.8% in 2023, then jumped by 96 bps to 2.79% in 2024, then surged by 1646 bps to 43.1% in 2025, then climbed by 24 bps to 53.31% in 2026.
• Business Quant data shows AUPH's Operating Margin at 53.31% in Q1 2026, 43.1% in Q4 2025, and 40.49% in Q3 2025.